A Clinical Trial Using Metronomic Oral Low-dose Cyclophosphamide Alternating With Low-dose Oral Methotrexate With Continuous Celecoxib and Weekly Vinblastine in Children and Adolescents With Relapsed or Progressing soliD Tumours.

NCT01285817 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

79

Enrollment

OTHER

Sponsor class

Conditions

Survival Without Progression

Interventions

DRUG: celecoxib, Vinblastine, Cyclophosphamide , methotrexate ,

Sponsor

Assistance Publique Hopitaux De Marseille